Abnormalities in receptor tyrosine kinase and serine/threonine kinase signalling pathways have been implicated in the development of cardiac hypertrophy, a condition characterised by enlargement of heart muscle cells, which can lead to heart failure and sudden cardiac death. The mechanisms underlying progression to cardiac hypertrophy remain poorly understood. In this study, a group led by Matthew J. Wolf described the first Drosophila model of the disorder. The authors report that the affected flies recapitulate the canonical features of human cardiac hypertrophy, including enlargement of cardiomyocytes and a decrease in the volume of the cardiac lumen in response to Raf-mediated molecular signals. This new model, which is free from the complexities associated with mammalian cardiac systems, could provide a platform for the discovery of downstream signalling molecules that contribute to cardiac hypertrophy in humans. Page 964
A new Drosophila model of cardiac hypertrophy
A new Drosophila model of cardiac hypertrophy. Dis Model Mech 1 July 2013; 6 (4): 867. doi:
Download citation file:
Advertisement
Cited by
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Other journals from
The Company of Biologists